RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00058257.xml
PDF herunterladen
CC BY-NC-ND 4.0 · Indographics 2024; 03(02): 064-081
DOI: 10.1055/s-0044-1787792
DOI: 10.1055/s-0044-1787792
Review Article
Pulmonary Tuberculosis in Immunocompromised Patients: A Review
Funding None.
Abstract
Tuberculosis (TB) remains a leading cause of morbidity and mortality worldwide and in India. Immunocompromised individuals, including those with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS), cancer, diabetes, or those undergoing immunosuppressive therapy, are at a heightened risk of developing TB, often presenting with atypical symptoms, imaging features, and more severe disease outcomes. This review highlights the atypical radiological pattern of TB in these states. It is well recognized that there is considerable overlap of imaging findings across a variety of pulmonary infections and noninfectious processes. The presence or absence of specific indicators and consideration of clinical factors can help narrow the differential diagnoses. Thereby, it is crucial for radiologists to identify the imaging features that not only are characteristic of pulmonary TB but also interpret the atypical findings and corroborate with appropriate clinical history, especially concerning the immune status of the patient, to provide crucial information while minimizing radiation exposure and patient expenditures for the best possible care.
Publikationsverlauf
Artikel online veröffentlicht:
24. Juli 2024
© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 WHO. Global Tuberculosis Report 2023. Accessed March 5, 2024 at: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2023
- 2 Bhalla AS, Goyal A, Guleria R, Gupta AK. Chest tuberculosis: Radiological review and imaging recommendations. Indian J Radiol Imaging 2015; 25 (03) 213-225
- 3 WHO. WHO consolidated guidelines on tuberculosis: module 2—screening: systematic screening for tuberculosis disease. Accessed April 1, 2024 at: https://www.who.int/publications-detail-redirect/9789240022676
- 4 Rozenshtein A, Hao F, Starc MT, Pearson GDN. Radiographic appearance of pulmonary tuberculosis: dogma disproved. AJR Am J Roentgenol 2015; 204 (05) 974-978
- 5 Park JH, Choe J, Bae M. et al. Clinical characteristics and radiologic features of immunocompromised patients with pauci-bacillary pulmonary tuberculosis receiving delayed diagnosis and treatment. Open Forum Infect Dis 2019; 6 (02) ofz002
- 6 Lewinsohn DM, Leonard MK, LoBue PA. et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis 2017; 64 (02) e1-e33
- 7 Kobashi Y, Mouri K, Yagi S. et al. Clinical features of immunocompromised and nonimmunocompromised patients with pulmonary tuberculosis. J Infect Chemother 2007; 13 (06) 405-410
- 8 CDC. Latent Tuberculosis Infection Resources | TB | CDC. Accessed February 19, 2024 at: https://www.cdc.gov/tb/publications/ltbi/ltbiresources.htm
- 9 WHO. Tuberculosis. 2024 . Accessed February 19, 2024 at: https://www.who.int/health-topics/tuberculosis
- 10 Balasubramaniam M, Pandhare J, Dash C. Immune control of HIV. J Life Sci (Westlake Village) 2019; 1 (01) 4-37
- 11 Van Woudenbergh E, Irvine EB, Davies L. et al. HIV is associated with modified humoral immune responses in the setting of HIV/TB coinfection. Msphere 2020; 5 (03) e00104-e00120
- 12 WHO. Regional Response Plan for TB-HIV 2017–2021. 2024 . Accessed April 1, 2024 at: https://iris.who.int/bitstream/handle/10665/254824/SEA-TB-370.pdf;jsessionid=A10206B690AD1B941DBBB21081BCE69C?sequence=1)%20Also
- 13 Tornheim JA, Dooley KE. Tuberculosis associated with HIV infection. Microbiol Spectr 2017 ;5(1)
- 14 Burger ZC, Aung ST, Aung HT, Rodwell T, Seifert M. 658. Effect of HIV status on tuberculosis load as detected by Xpert MTB/RIF in sputum vs. saliva samples. Open Forum Infect Dis 2020; 7 (Suppl. 01) S385-S386
- 15 Vimala L, Hubert N. Chest infections in immunocompromised patients. In: Irodi A, Chellathuri A, Jagia P. , et al., eds Comprehensive Textbook of Clinical Radiology. 1st. Gurugram: Elsevier India; 2023: 287-300
- 16 Kapadiya DJ, Dave PV, Vadera B, Patel PG, Chawla S, Saxena D. Assessment of tuberculosis prevalence in newly diagnosed human immunodeficiency virus-infected adults attending care and treatment center in Gujarat, India. Indian J Community Med 2018; 43 (03) 185-189
- 17 Reddy SG, Ali SY, Khalidi A. Study of infections among human immunodeficiency virus/acquired immunodeficiency syndrome patients in Shadan Hospital, Telangana, India. Indian J Sex Transm Dis AIDS 2016; 37 (02) 147-150
- 18 Padyana M, Bhat RV, Dinesha M, Nawaz A. HIV-tuberculosis: a study of chest X-ray patterns in relation to CD4 count. N Am J Med Sci 2012; 4 (05) 221-225
- 19 Frey V, Phi Van VD, Fehr JS. et al. Prospective evaluation of radiographic manifestations of tuberculosis in relationship with CD4 count in patients with HIV/AIDS. Medicine (Baltimore) 2023; 102 (07) e32917
- 20 Quinn CM, Poplin V, Kasibante J. et al. Tuberculosis IRIS: pathogenesis, presentation, and management across the spectrum of disease. Life (Basel) 2020; 10 (11) 262
- 21 Krishna S, Jacob JJ. Diabetes mellitus and tuberculosis. In: Feingold KR, Anawalt B, Blackman MR. et al, eds. Endotext. South Dartmouth, MA: MDText.com, Inc.; 2000
- 22 Zafar MI, Chen LL, Xiaofeng Y, Gao F. Impact of diabetes mellitus on radiological presentation of pulmonary tuberculosis in otherwise non-immunocompromised patients: a systematic review. Curr Med Imaging 2019; 15 (06) 543-554
- 23 Kumar NP, Fukutani KF, Shruthi BS. et al. Persistent inflammation during anti-tuberculosis treatment with diabetes comorbidity. eLife 2019; 8: e46477
- 24 Ayelign B, Negash M, Genetu M, Wondmagegn T, Shibabaw T. Immunological impacts of diabetes on the susceptibility of Mycobacterium tuberculosis . J Immunol Res 2019; 2019: 6196532
- 25 Yew WW, Leung CC, Zhang Y. Oxidative stress and TB outcomes in patients with diabetes mellitus?. J Antimicrob Chemother 2017; 72 (06) 1552-1555
- 26 Podell BK, Ackart DF, Obregon-Henao A. et al. Increased severity of tuberculosis in Guinea pigs with type 2 diabetes: a model of diabetes-tuberculosis comorbidity. Am J Pathol 2014; 184 (04) 1104-1118
- 27 Jha V, Garcia-Garcia G, Iseki K. et al. Chronic kidney disease: global dimension and perspectives. Lancet 2013; 382 (9888) 260-272
- 28 Zuo L, Wang M. Chinese Association of Blood Purification Management of Chinese Hospital Association. Current burden and probable increasing incidence of ESRD in China. Clin Nephrol 2010; 74 (Suppl. 01) S20-S22
- 29 Romanowski K, Clark EG, Levin A, Cook VJ, Johnston JC. Tuberculosis and chronic kidney disease: an emerging global syndemic. Kidney Int 2016; 90 (01) 34-40
- 30 Hussein MM, Mooij JM, Roujouleh H. Tuberculosis and chronic renal disease. Semin Dial 2003; 16 (01) 38-44
- 31 Segall L, Covic A. Diagnosis of tuberculosis in dialysis patients: current strategy. Clin J Am Soc Nephrol 2010; 5 (06) 1114-1122
- 32 Das A, Naranje P, Bhalla AS, Das CJ. Imaging of pulmonary manifestations in chronic kidney disease: a review. Indographics. 2023; 02 (02) 095-108
- 33 Singh R, Naranje P, Bhalla AS, Pandey S. Magnetic resonance imaging in response assessment of mediastinal tuberculous lymphadenopathy: going beyond size. Lung India 2021; 38 (05) 431-437
- 34 Lopez de Castilla D, Schluger NW. Tuberculosis following solid organ transplantation. Transpl Infect Dis 2010; 12 (02) 106-112
- 35 Giacomelli IL, Schuhmacher Neto R, Marchiori E, Pereira M, Hochhegger B. Chest X-ray and chest CT findings in patients diagnosed with pulmonary tuberculosis following solid organ transplantation: a systematic review. J Bras Pneumol 2018; 44 (02) 161-166
- 36 Jung JI, Lee DG, Kim YJ, Yoon HK, Kim CC, Park SH. Pulmonary tuberculosis after hematopoietic stem cell transplantation: radiologic findings. J Thorac Imaging 2009; 24 (01) 10-16
- 37 Song M, Kim SJ, Yoo JY. Corticosteroid-induced exacerbation of cryptic miliary tuberculosis to acute respiratory distress syndrome: a case report. Medicine (Baltimore) 2020; 99 (46) e23204
- 38 Jung SM, Han M, Kim EH, Jung I, Park YB. Comparison of developing tuberculosis following tumor necrosis factor inhibition and interleukin-6 inhibition in patients with rheumatoid arthritis: a nationwide observational study in South Korea, 2013-2018. Arthritis Res Ther 2022; 24 (01) 157
- 39 Schleicher GK, Feldman C. Dual infection with Streptococcus pneumoniae and Mycobacterium tuberculosis in HIV-seropositive patients with community acquired pneumonia. Int J Tuberc Lung Dis 2003; 7 (12) 1207-1208
- 40 Grover SB, Grover H, Antil N, Patra S, Sen MK, Nair D. Imaging approach to pulmonary infections in the immunocompromised patient. Indian J Radiol Imaging 2022; 32 (01) 81-112
- 41 Tanaka N, Kunihiro Y, Yanagawa N. Infection in immunocompromised hosts: imaging. J Thorac Imaging 2018; 33 (05) 306-321
- 42 Ravenel JG, Chung JH, Ackman JB. et al; Expert Panel on Thoracic Imaging. ACR Appropriateness Criteria® imaging of possible tuberculosis. J Am Coll Radiol 2017; 14 (5S): S160-S165
- 43 Hasan T, Au E, Chen S, Tong A, Wong G. Screening and prevention for latent tuberculosis in immunosuppressed patients at risk for tuberculosis: a systematic review of clinical practice guidelines. BMJ Open 2018; 8 (09) e022445